相关实验视频

Updated: Jun 30, 2025

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

分析大脑-肠轴和帕金森病的参考资料

Lingshan Chen^1,2, Jianfei Chen¹, Min Wu¹

¹Medical Laboratory Specialty, The Second Hospital of Jinhua, Jinhua, Zhejiang Province, China.

Frontiers in neurology

|March 22, 2024

概括

对大脑-肠轴和帕金森病 (PD) 研究的图书统计分析显示,出版物显著增加. 未来的研究应该集中在肠道微生物群功能和个性化PD治疗的干预设计上.

科学领域:

神经科学是一个神经科学.
微生物学微生物学
图书统计学图书统计学

背景情况:

帕金森病 (PD) 涉及多巴胺基神经元损失.
越来越多的证据将肠道微生物群与PD联系起来.
了解大脑-肠轴和PD的研究趋势至关重要.

研究的目的:

为了对大脑-肠轴和PD文献进行全面的文献分析.
确定研究兴趣,学科背景和未来方向.
分析2014年至2023年的出版物.

主要方法:

在 Web of Science 核心收藏中进行文献搜索.
使用Biblioshiny R包和VOSviewer进行数据分析.
使用了文献计量指标和关键词分析.

主要成果:

出版物的显著上升趋势,年增长率为50.24%.
中国,美国和意大利是最大的出版国;"国际分子科学杂志"在出版物方面领先.
关键词包括"α-synuclein"",鼠标模型"",炎症"",风险"",中枢神经系统"和"肠道细菌过度生长".

结论:

这项研究强调了脑肠轴和PD的当前趋势和研究热点.
未来的研究应该调查肠道微生物群的功能和代谢作用.
过渡到干预性研究可以实现个性化的PD干预和预测.

关键词:

图书馆计数器R 在线阅读帕金森病是帕金森氏症的一种疾病.在VOSviewer中使用VOSviewer.文献计量分析的分析大脑-肠轴 - 大脑-肠轴

更多相关视频

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis

Published on: July 28, 2023

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...